91 related articles for article (PubMed ID: 23412841)
1. Computational investigation of cancer-associated molecular mechanism in Aurora A (S155R) mutation.
Kumar A; Rajendran V; Sethumadhavan R; Purohit R
Cell Biochem Biophys; 2013 Jul; 66(3):787-96. PubMed ID: 23412841
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis.
Gupta A; Jain R; Wahi D; Goyal S; Jamal S; Grover A
J Recept Signal Transduct Res; 2015; 35(6):626-33. PubMed ID: 26390942
[TBL] [Abstract][Full Text] [Related]
3. Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation.
Bhardwaj VK; Purohit R
J Biomol Struct Dyn; 2021 Jul; 39(11):3882-3891. PubMed ID: 32448055
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of specific binding between Aurora A and TPX2 by molecular dynamics simulations.
Cheng Y; Zhang F; Chen Q; Gao J; Cui W; Ji M; Tung CH
J Chem Inf Model; 2011 Oct; 51(10):2626-35. PubMed ID: 21919471
[TBL] [Abstract][Full Text] [Related]
5. A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix.
Rennie YK; McIntyre PJ; Akindele T; Bayliss R; Jamieson AG
ACS Chem Biol; 2016 Dec; 11(12):3383-3390. PubMed ID: 27775325
[TBL] [Abstract][Full Text] [Related]
6. A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2.
Bibby RA; Tang C; Faisal A; Drosopoulos K; Lubbe S; Houlston R; Bayliss R; Linardopoulos S
J Biol Chem; 2009 Nov; 284(48):33177-84. PubMed ID: 19801554
[TBL] [Abstract][Full Text] [Related]
7. Gain of native conformation of Aurora A S155R mutant by small molecules.
Tanwar G; Purohit R
J Cell Biochem; 2019 Jul; 120(7):11104-11114. PubMed ID: 30746758
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex.
Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A
Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.
McIntyre PJ; Collins PM; Vrzal L; Birchall K; Arnold LH; Mpamhanga C; Coombs PJ; Burgess SG; Richards MW; Winter A; Veverka V; Delft FV; Merritt A; Bayliss R
ACS Chem Biol; 2017 Nov; 12(11):2906-2914. PubMed ID: 29045126
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2.
Zorba A; Buosi V; Kutter S; Kern N; Pontiggia F; Cho YJ; Kern D
Elife; 2014 May; 3():e02667. PubMed ID: 24867643
[TBL] [Abstract][Full Text] [Related]
11. Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.
Chu TLH; Connell M; Zhou L; He Z; Won J; Chen H; Rahavi SMR; Mohan P; Nemirovsky O; Fotovati A; Pujana MA; Reid GSD; Nielsen TO; Pante N; Maxwell CA
Mol Cancer Res; 2018 Jan; 16(1):16-31. PubMed ID: 28993511
[TBL] [Abstract][Full Text] [Related]
12. NQO1 prevents radiation-induced aneuploidy by interacting with Aurora-A.
Park MT; Oh ET; Song MJ; Lee H; Choi EK; Park HJ
Carcinogenesis; 2013 Nov; 34(11):2470-85. PubMed ID: 23803694
[TBL] [Abstract][Full Text] [Related]
13. TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.
van Gijn SE; Wierenga E; van den Tempel N; Kok YP; Heijink AM; Spierings DCJ; Foijer F; van Vugt MATM; Fehrmann RSN
Oncogene; 2019 Feb; 38(6):852-867. PubMed ID: 30177840
[TBL] [Abstract][Full Text] [Related]
14. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564
[TBL] [Abstract][Full Text] [Related]
15. Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity.
Kumar A; Rajendran V; Sethumadhavan R; Purohit R
J Biomol Struct Dyn; 2014; 32(3):394-405. PubMed ID: 23527964
[TBL] [Abstract][Full Text] [Related]
16. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.
Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL
Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for activation of Aurora-A kinase by Ajuba.
Bai M; Ni J; Wu J; Wang B; Shen S; Yu L
Gene; 2014 Jun; 543(1):133-9. PubMed ID: 24680704
[TBL] [Abstract][Full Text] [Related]
18. Two TPX2-dependent switches control the activity of Aurora A.
Xu X; Wang X; Xiao Z; Li Y; Wang Y
PLoS One; 2011 Feb; 6(2):e16757. PubMed ID: 21347367
[TBL] [Abstract][Full Text] [Related]
19. Two newly identified sites in the N-terminal regulatory domain of Aurora-A are essential for auto-inhibition.
Bai M; Ni J; Shen S; Wu J; Huang Q; Le Y; Yu L
Biotechnol Lett; 2014 Aug; 36(8):1595-604. PubMed ID: 24682789
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy.
de Souza VB; Kawano DF
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129448. PubMed ID: 31676293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
